Agreement

AMENDMENT to the April 15, 2003 Clinical Coating Agreement

by Cabg Medical Inc
September 2nd, 2004
 

EXHIBIT 10.17

AMENDMENT
to the
April 15, 2003 Clinical Coating Agreement

This Amendment to the April 15, 2003 Clinical Coating Agreement (the “Agreement”) is by and between SurModics, Inc. (SURMODICS) and CABG Medical, Inc. (CABG) and shall be effective June 30, 2004.

The parties desire to extend the term of the Agreement. Accordingly, the parties agree to modify sections 2.2 and 2.4 of the Agreement to read as follows:

2.2       Grant. SURMODICS grants CABG the limited right to use Product coated by SURMODICS under this Agreement in human clinical trials, such period of utilization ending December 31, 2005.

2.3      Coating Period and Quality. For the period ending December 31, 2005, SURMODICS shall coat up to 1000 units of Product (each unit consisting of one stent coupling and one throttle).

IN WITNESS WHEREOF, the parties hereto execute this Amendment by their duly authorized employees.

     
Accepted by:
  Accepted by:
SurModics, Inc.
  CABG Medical, Inc.
 
   
/s/ GREGORY T. YUNG
  /s/ JOHN BABITT

 
 
 
Signature
  Signature
 
   
GREGORY T. YUNG
  JOHN BABITT

 
 
 
Printed Name
  Printed Name
 
   
Vice President
  President

 
 
 
Title
  Title